Aeon Biopharma (AEON) announced the appointment of Rob Bancroft as president and CEO, effective April 29. Bancroft will also join Aeon’s board of directors. Bancroft brings over 25 years of experience in the life sciences industry, spanning biopharmaceuticals, medical devices, and healthcare technology. Prior to joining Aeon he served as GM of the therapeutics business at Revance (RVNC).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AEON: